Where Does Your Urolithin A Actually Come From? What 'Pomegranate-Derived' Claims Really Mean

If a urolithin A product describes itself as "pomegranate-derived," it's worth pausing on that phrase before it goes into your own marketing copy. Urolithin A isn't a compound you extract from pomegranate in any meaningful quantity — and understanding why matters for how you evaluate a supplier.

Urolithin A Isn't Really "In" Pomegranate

Pomegranates (along with walnuts and certain berries) contain ellagitannins and ellagic acid — not urolithin A itself. Urolithin A is a downstream metabolite: gut bacteria convert ellagitannins into ellagic acid, and then further into urolithin A, over the course of digestion. Critically, only a subset of people — often referred to as "urolithin metabotype A" — carry the specific gut bacterial populations needed to complete this conversion efficiently. In everyone else, conversion is minimal or absent. Even in people who do convert well, yields are low and highly variable batch to batch, person to person, and meal to meal.

For procurement, distinguish a dietary precursor, a metabolic origin and the manufacturing route of a supplied Urolithin A powder. Ask the supplier to document the route for the actual material rather than inferring it from a pomegranate-related marketing phrase.

How Commercial-Grade Urolithin A Is Actually Made

A commercial Urolithin A powder specification should define identity, purity or assay basis, relevant impurities and lot traceability. Manufacturing-route information should be supported by the supplier documents for that material.

The purchasing question is whether the documented production route, product identity and batch results match the supplied ingredient and the claims being made.

What to Verify Before You Buy

• Ask directly how the material is manufactured. A supplier should be able to describe their actual production route without vague language.
• Request the batch-specific HPLC chromatogram, not just an assay number. Because urolithin A has structurally similar regioisomers and synthesis-related byproducts, the chromatogram matters as much as the headline purity figure.
• Confirm the reference standard used for identification and assay.
• Consider independent third-party testing before committing to a large-volume order, particularly if the ingredient will support a health claim in your finished product.

How PathGene Approaches This

PathGene currently lists Urolithin A powder, CAS 1143-70-0, at ≥99.0% purity. The disclosed reference COA for PGUA-260112 separately reports a ≥98% purity limit and a 99.7% result; its dry-basis assay result is 99.6%. Read that historical lot document separately from the current product specification, and confirm the agreed specification and COA for the shipment. Powder properties and any requested formulation grade require separate confirmation.

Related sourcing resources: Review the product specification before requesting a sample.

For batch documentation and release checks, see our quality and analytical documentation.

Qualify the powder for the intended dosage form

Source identity does not establish particle size or formulation performance. For capsule, tablet or powder projects, define the required powder properties and compare evaluation samples under the intended process.

• Confirm the particle-size or mesh requirement and the measurement method; do not infer it from a purity result.
• Record sample batch, preparation conditions and dispersion or process observations.
• Agree the release specification and the documents required for the commercial lot.

A standard powder is not automatically a micronized, liposomal or encapsulated grade. Confirm availability and supporting evidence before specifying such a material.

Request a Urolithin A evaluation sample or bulk quote · Review batch quality documents